The vein-to-vein supply chain: Designing zero-failure courier networks for cell and gene therapy
Cell and gene therapies are redefining what is possible in medicine—but they are also redefining the stakes of supply chain execution. In a vein-to-vein model, every shipment represents a single patient, a narrow time window, and an irreversible outcome. Unlike traditional pharmaceuticals, there is no inventory buffer, no reshipment, and no margin for error.
Key Takeaways:
- 1. Explore how to design and operate zero-failure courier networks for cell and gene therapy
- 2. Examine real-world risk points, common failure modes
- 3. Understand the operational strategies required to ensure that life-changing therapies move safely, compliantly, and reliably from patient to patient—every time
#cgt #cellandgene